Veranex Executive and Leadership Team

Megan Osorio, the Chief Executive Officer at Veranex, directs the overarching strategic vision for this global medical technology service provider. Osorio architects the long-term growth trajectory by aligning engineering, regulatory, clinical, and market access pillars into a unified development framework. By prioritizing accelerated speed to market, the Chief Executive Officer ensures that medical device innovators mitigate development risks while maintaining cost efficiency. Osorio manages high-level interactions with the Board to secure resources for expanding the company's international footprint. Through rigorous oversight of market viability assessments, Megan Osorio drives the organization toward sustainable commercial success. This leadership role demands constant vigilance regarding industry shifts and technological advancements. Ultimately, Osorio secures the competitive advantage of the firm by fostering a culture of excellence and precision across all service lines, ensuring that every client project benefits from the comprehensive expertise inherent in the Veranex model.

Sylvain Duval, the Chief Financial Officer at Veranex, manages the fiscal health and capital allocation strategies for this comprehensive medical technology service provider. Duval oversees the financial planning and analysis functions, ensuring that development costs remain controlled across all four pillars of the business. By implementing robust financial reporting systems, the Chief Financial Officer provides the transparency necessary for informed decision-making at the executive level. Sylvain Duval monitors global market trends to optimize resource distribution, supporting the firm's mission to accelerate client speed to market. This role involves close collaboration with other C-suite leaders to evaluate the financial impact of new service offerings and geographic expansion. Through disciplined budget management and risk assessment, Duval protects the long-term stability of the organization. Ultimately, the Chief Financial Officer drives the financial performance required to sustain the company's position as a leader in the medical technology consulting sector.

David Dockhorn, the Chief Operating Officer at Veranex, directs the internal operational workflows and service delivery mechanisms for this global medical technology partner. Dockhorn architects scalable processes that unify engineering, regulatory, clinical, and market access teams, ensuring seamless project execution. By optimizing operational efficiency, the Chief Operating Officer reduces development timelines for clients, directly supporting the company's core mission of accelerated market viability. David Dockhorn manages the integration of tech-enabled tools across all service pillars to maintain high standards of quality and compliance. This leadership role requires constant coordination with department heads to resolve bottlenecks and enhance cross-functional collaboration. Through the implementation of standardized operational protocols, Dockhorn ensures that the firm delivers consistent value across diverse international markets. Ultimately, the Chief Operating Officer drives the operational excellence necessary to maintain the company's reputation as a premier provider of comprehensive medical technology solutions.

Michel Bourdoncle, the President at Veranex, directs the day-to-day execution of the company's business strategy across its global medical technology service operations. Bourdoncle architects the tactical implementation of the firm's four pillars, ensuring that engineering, regulatory, clinical, and market access services remain integrated and effective. By overseeing client relationships and service delivery quality, the President ensures that the organization meets its commitment to accelerated speed to market. Michel Bourdoncle collaborates with the Chief Executive Officer to translate high-level vision into actionable plans that drive revenue growth and market penetration. This leadership role involves managing the performance of regional teams to ensure consistent service delivery across international borders. Through the active monitoring of project milestones and client satisfaction metrics, Bourdoncle maintains the firm's competitive edge. Ultimately, the President drives the operational momentum necessary to solidify the company's status as the leading tech-enabled provider in the medical technology industry.

Doug Dockhorn, the Chief Administrative Officer (CAO) at Veranex, manages the organizational infrastructure and corporate governance frameworks that support this global medical technology service provider. Dockhorn oversees human capital management, internal policy development, and administrative systems to ensure the company operates with maximum agility. By streamlining corporate processes, the Chief Administrative Officer (CAO) enables the engineering, regulatory, clinical, and market access teams to focus entirely on client outcomes. Doug Dockhorn facilitates cross-departmental communication, ensuring that administrative support aligns with the strategic goals set by the executive team. This role involves managing the firm's internal resources to support expansion into new geographic regions while maintaining strict compliance standards. Through the optimization of corporate services, Dockhorn fosters an environment conducive to innovation and professional growth. Ultimately, the Chief Administrative Officer (CAO) drives the structural integrity required to sustain the company's comprehensive service model in a complex, highly regulated industry.